Articles tagged with Cancer Treatments
Researchers found that sirolimus reduced angiomyolipoma size by nearly 50% in TSC and LAM patients. Lung function also improved in LAM patients, with a 10-15% increase in expiratory air flow.
Researchers discovered that a transient and local rise in interleukin-6 (IL-6) is essential for the growth of muscle fibers. This finding could lead to new treatments for reversing or improving muscle loss in diseases such as cancer and AIDS, as well as normal aging.
A new study by Fox Chase Cancer Center reveals that most American adults engage in multiple behaviors increasing their exposure to UV rays, including infrequent sun protection and indoor tanning. The study found that younger adults, men, Caucasians, smokers, and those with fair skin are more likely to engage in these high-risk behaviors.
Cancer risk increases with age, yet elderly nursing home residents receive relatively few cancer care services. According to a recent study, only 28% of patients with late-stage cancer received hospice care, highlighting the need for further investigation into cancer care in this population.
Bevacizumab plus interferon improves progression-free survival in patients with metastatic renal cell carcinoma compared to interferon alone. The new treatment option is expected to provide a better prognosis for patients with renal cancer.
A survey of 367 women with advanced breast cancer underscores the significance of emotional and educational needs, with psychosocial support identified as a high priority. The study also reveals dissatisfaction with treatment experiences and highlights the importance of internet access as an information resource for patients.
A Mayo Clinic program has reduced delays between abnormal mammograms and diagnosis, improving outcomes for women with cancer. The clinic's multidisciplinary breast clinic helped overcome barriers such as lack of transportation and childcare, providing timely care to underserved women.
A study published in Dermatologic Therapy reveals that rituximab effectively treats blistering skin diseases, including paraneoplastic pemphigus, by targeting abnormal immune responses. The drug's efficacy is being explored for other serious dermatological disorders, but its indications are still being defined.
Researchers at UMass Medical School discovered a complex pathway that allows cells to survive and die through autophagy, a process previously misunderstood. The study sheds light on the relationship between autophagy and cell death, with potential implications for cancer, Alzheimer's, and Parkinson's treatments.
Research findings suggest a genetic link between schizophrenia and cancer, while also exploring the relationship between depression and heart disease. Studies on brain overgrowth in autistic children and the development of an animal model for autism have also shed light on these complex conditions.
A phase II trial of Cybor-D, a combination therapy including cyclophosphamide, bortezomib, and dexamethasone, showed an improved response rate compared to traditional lenalidomide-dexamethasone therapy. The treatment resulted in a rapid initial decline and percentage reduction in M protein levels.
A recent study has identified a link between BRCA1 mutations and the loss of the tumor suppressor gene PTEN in breast cancer. This discovery opens up new avenues for treating aggressive forms of breast cancer by targeting proteins in the PTEN pathway.
Researchers found that diets rich in raw vegetables can prevent or slow the growth of some common cancers. Black raspberries may protect against esophageal cancer by reducing oxidative stress, while broccoli sprouts inhibit bladder cancer development through the delivery of cancer prevention agents.
A Virginia Commonwealth University research team has received a $1.3 million NCI grant to improve histone deacetylase inhibitors in treating leukemia. The goal is to develop novel combination regimens incorporating these agents with NF-kappa B antagonists.
A recent survey found that nearly half of respondents would choose an endodontist for their root canal procedure. The American Association of Endodontists reports that endodontists perform an average of 25 root canals per week, significantly more than general dentists who perform about two a week.
A purified bacterial extract spray administered to laboratory mice provided powerful protection against all four major classes of pathogens, including anthrax and bubonic plague. The treatment was shown to stimulate a healthy immune response and increase antimicrobial polypeptides in the lung lining fluid.
A study by American Cancer Society researchers found significant disparities in breast cancer diagnosis, particularly among uninsured and African American women. They are more likely to miss axillary lymph node assessments, which help determine stage and guide treatment decisions.
Researchers identified a role for OX40 in TSLP-induced allergic reactions, finding that blocking its interaction reduced allergic responses in mice and monkeys with asthma. The study suggests OX40-OX40L interactions as a promising therapeutic target for treating allergic diseases.
A study by Dr. Groesbeck Parham found that 90% of HIV-infected women presenting for antiretroviral therapy harbor cervical cell abnormalities, increasing the risk of cervical cancer. Access to screening and treatment is crucial to prevent this life-threatening condition in women living with AIDS.
A recent study found racial discrepancies in breast cancer tumor gene profiles, suggesting inflammation plays a stronger role in development and progression in African-American women. African-American breast cancer patients tend to have a greater prevalence of an aggressive form of cancer less likely to respond to hormone therapy.
A systematic review of recent studies suggests PET imaging can accurately diagnose and stage lung cancer, even in early stages. The imaging modality is found to be more accurate than CT imaging for treatment decisions in non–small-cell lung cancer patients.
A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors found that all patients remained cancer-free for up to two and a half years after the procedure. The treatment's effectiveness was demonstrated by the successful elimination of 89 out of 91 tumors in a single treatment session.
Papers published in this issue highlight the value of multidisciplinary collaboration, revealing treatments that spare patients' eyes during cancer treatment and develop new techniques to increase orbital volume. These advancements demonstrate enormous opportunities for knowledge advancement through specialty collaboration.
A structured support program improved prostate cancer patients' and their spouses' lives by addressing symptom management, hope, and couples' communication. The intervention also reduced mental health distress and increased physical quality of life.
Researchers identified distinct molecular markers predicting subsequent invasive cancer after noninvasive breast cancer diagnosis. These biomarkers can stratify women's individual risk and guide aggressive therapy decisions.
Researchers have discovered that the FTO gene influences weight gain by modifying DNA, suggesting a role in controlling hunger and satiety. The study found that the FTO variant is common and associated with increased risk of obesity and diabetes, paving the way for potential therapeutic manipulation.
Researchers at UBC discover a process called chromatin remodeling that allows certain cancer cells to hide from the immune system by altering the structure of chromosomes. This 'instruction manual' enables cancer cells to evade detection and grow unchecked, but the discovery may lead to new therapies within five to 10 years.
A panel of experts proposes a definition of recovery as a voluntarily maintained lifestyle characterized by sobriety, personal health, and citizenship. The proposed definition includes classification of duration of sobriety and recognition of the importance of personal health and citizenship in achieving true recovery.
Researchers at MIT have made significant advances toward a novel therapeutic device that can selectively provide signals to cells traveling through the bloodstream. The technology leverages cell rolling, a biological process that slows down cells as they flow through blood vessels, allowing them to sense signals from nearby tissues.
A new study published in CANCER found that despite significant increases in healthcare expenditures, survival rates for elderly patients with lung cancer remained relatively stable between 1983 and 1997. The average life-expectancy rose by less than one month, while costs increased by over $20,000 per patient.
Researchers developed a computational model to predict TB reactivation causes and developed a TNF-modulating agent to balance inflammation reduction with infection resistance. Modifying anti-TNF treatment dosages and timing or using TB antibiotics before treatment can also prevent reactivation, according to the study.
Researchers at CSHL have identified three genes causing 20% of lung cancers that interact to reactivate fetal gene expression patterns leading to tumor growth. Reversing these genes may lead to new treatment options for patients.
The NIBIB Quantum Grants program funds four innovative projects to develop new technologies for metastatic lung cancer diagnosis, bio-artificial kidneys, insulin-producing cells, and nanoparticles targeting brain tumors. These advancements aim to transform healthcare with potential breakthroughs in disease treatment and prevention.
A study by ANZAC Research Institute suggests that a calcium deficiency can increase the likelihood of advanced breast cancer targeting bones. Dietary calcium intake could help prevent this spread and serve as an adjuvant treatment during therapy.
A study by Johns Hopkins researchers found that standard androgen deprivation therapy for prostate cancer may increase the production of nestin, a protein that promotes cell migration and metastasis. The therapy is effective in slowing tumor growth but may inadvertently encourage cancer cells to spread throughout the body.
A large study of Norwegian women with cancer found that pregnancy did not affect survival rates, except for breast cancer diagnosed during lactation where mortality was higher. The study tracked 45,511 women over eight years and compared their survival rates to non-pregnant patients.
A growing global cancer burden threatens low-to-medium resource countries due to limited health budgets and high communicable disease rates. Europe's successful cancer control policies demonstrate a viable approach that can be extended to these regions.
Effective communication is essential for good cancer care, according to a new report by the National Cancer Institute. The report highlights the need for patients to have access to clear information about their treatment options and outcomes, as well as the importance of patient-centered communication in managing uncertainty and anxiety.
Researchers have developed a new blood screening technique that can detect early-stage liver cancer and predict treatment outcomes. They detected an altered version of RASSF1A, a tumor-suppressing gene, in the blood of HCC patients and HBV-infected test subjects, with promising results.
Researchers developed an acoustic sensor that can detect small amounts of mesothelin, a biomarker associated with several cancers. The device uses electrodes and antibodies to identify changes in frequency caused by the presence of mesothelin.
A University of Minnesota study found no evidence that prostate cancer is more aggressive in black men, contradicting previous studies. The research matched patients by age, Gleason grade, clinical stage, and PSA levels before prostatectomy.
A new initiative aims to better understand and enhance patient participation in clinical trials. Researchers will use socio-psychological approaches to identify factors influencing patients' decisions to participate. The project has the potential to increase patient accrual rates, leading to faster development of novel treatments.
A new study reveals that noncoding RNAs play a significant role in human cancer, with altered expression of ultraconserved noncoding RNAs consistently found in leukemias and carcinomas. The findings suggest a model where both coding and noncoding genes cooperate in tumorigenesis.
Researchers at Rensselaer Polytechnic Institute are developing a personal device to measure daily light intake and activity, predicting optimal timing for light therapy to synchronize the circadian clock. The device aims to alleviate psychosocial stress and sleep-related ailments caused by inadequate or irregular light exposure.
University of Minnesota researchers have initiated a groundbreaking clinical trial to determine the optimal dose and safety of T regulatory cells from umbilical cord blood in decreasing the risk of immune reactions common in patients undergoing blood and marrow transplantation. The study aims to enhance blood and marrow recovery, reduc...
A specific gene mutation, BRAF V600E, is associated with increased risk of recurrence and death in thyroid cancer patients. The mutation can help guide treatment options and follow-up care, including aggressive surgery and radioiodine therapy.
Researchers at the University of Chicago Medical Center found that family-based treatment, which involves parents, doubled the percentage of teens who abstained from binge eating and purging after six months. The study involved 80 adolescents with bulimia nervosa or partial bulimia nervosa.
Researchers identified a region on chromosome 5p associated with dense breast tissue, a known risk factor for breast cancer. Women with dense breasts are three to five times more likely to develop breast cancer than those with less dense breasts.
A study by St. Jude Children's Research Hospital reveals the loss of Arf gene and BCR-ABL mutation leaves cells vulnerable to growth-enhancing environment of bone marrow, promoting immunity to anti-leukemia drug imatinib.
A research letter investigates the feasibility of self-collected HPV specimens for testing among women at high risk of cervical cancer. The study found that outreach nurses were able to recontact 81.4% of participants who tested positive and referred them for further testing.
Patients with Medicaid and those lacking insurance have a higher risk of being diagnosed with advanced-stage laryngeal cancer at diagnosis. This association holds true across various demographic groups, emphasizing the importance of access to healthcare for cancer screening and treatment.
Researchers have discovered that sulforaphane can prevent severe blistering and skin breakage associated with the rare genetic disease EBS. The study, funded by various organizations, found marked improvement in treated mice, suggesting a potential therapeutic for this condition.
Researchers at Durham University have created a chemical compound containing fluorine that can be used in a 'chemically-sensitive MRI scan' to identify disease progression without biopsies. The compound reacts differently according to body acidity levels, highlighting tumors on the resulting scan.
Researchers found that bursts of waves drive immune system 'soldiers' toward invaders, using a signaling protein to direct cell movement. The discovery may lead to strategies to block cancer growth and treat heart disease.
Researchers discovered the p75NTR receptor plays a key role in glioma invasion, with expression sufficient to induce aggressive tumor growth. This finding highlights a previously unknown function of the receptor and suggests it may be a novel therapeutic target.
Researchers found that green tea concentrate increased GST enzyme activity by up to 80% in people with low levels, suggesting a potential mechanism for its anti-cancer properties. The study suggests that green tea may help strengthen metabolic defense against toxins capable of causing cancer.
Researchers at Virginia Commonwealth University identified two key proteins, KLF2 and EKLF, that regulate overlapping groups of genes during red blood cell development. The study may lead to future gene therapies for sickle cell anemia and beta-thalassemia.
Researchers found radiofrequency ablation to be 93% effective in eradicating malignant kidney tumors, with minimal discomfort and no serious complications. The study's lead author suggests this treatment is an excellent option for patients who are not good operative candidates or have multiple renal tumors.
A study of 125 kidney tumors treated with radiofrequency ablation showed a high cure rate and low complication rate. The procedure achieved a 93% success rate for all treated tumors, making it an alternative method for patients who are not good surgical candidates.
A Mayo Clinic-led collaborative study finds that focused ultrasound treatment of uterine fibroids offers sustained symptom relief and durable outcomes. The more complete destruction of tumors by focused ultrasound results in improved quality of life and lower incidence of severe side effects.